Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 1]
Phase 1 study evaluating the Litx BPH System for lower urinary tract symptoms associated with benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) [NA]
A clinical trial update notes that a study evaluating dutasteride after failure of finasteride for symptomatic benign prostatic hyperplasia …
-
FDA approval · 2012-09-28FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-09-28FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for finasteride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-09-27FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s supplemental application for finasteride under ANDA 090121.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-08-30FDA Approved: ALFUZOSIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Alfuzosin hydrochloride as a generic version of alfuzosin hydrochloride for the treatment of benign …
-
CLINICAL_TRIALS research · 2012-08-27Clinical Trial Update: Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database
GlaxoSmithKline completed a validation study using the MarketScan database to examine whether adherence to benign prostatic hyperplasia trea…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating the efficacy of electroacupuncture at bilateral BL33 points for mild to moderate benign prostatic hyperpla…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: TRADE-Testosterone Replacement and Dutasteride Effectiveness [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of testosterone replacement therapy in combination with dutasteride for men with hypogon…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy [NA]
A completed clinical trial evaluating a non-invasive heating garment for safety and efficacy in reducing urinary hesitancy in men with Benig…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate [NA]
A clinical trial evaluating plasmakinetic enucleation of the prostate for benign prostatic hyperplasia with a large prostate has completed.
-
FDA approval · 2012-06-27FDA Approved: JALYN — Supplemental Application (Waylis Therapeutics)
FDA approved a supplemental application for JALYN, the combination product of dutasteride and tamsulosin hydrochloride. The submission was b…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) [Phase 2]
A Phase 2 study of NX-1207 for Benign prostatic hyperplasia has completed.
-
FDA approval · 2012-06-07FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride submitted by Teva Pharmaceuticals USA, Inc. The approval updates an existing fin…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Comparison of Intrathecal Fentanyl or Sufentanil in 1 mg Bupivacaine Spinal Anesthesia for TURP in Elderly Patients [NA]
A completed trial comparing intrathecal fentanyl versus intrathecal sufentanil as adjuncts to 1 mg bupivacaine for spinal anesthesia in elde…
-
FDA approval · 2012-05-29FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved Dr. Reddy's Laboratories Limited's supplemental application for Finasteride, a generic product.
-
FDA approval · 2012-05-23FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves the supplemental application for Finasteride from Aurobindo Pharma Limited, granting a generic Finasteride product under the AN…
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia [Phase 1, Phase 2]
This document notes the completion of a dose-escalation, Phase 1/2 trial of QLT0074 for benign prostatic hyperplasia.
-
CLINICAL_TRIALS research · 2012-05-23Clinical Trial Update: Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon
A retrospective review of Holmium Laser Enucleation of the Prostate (HoLEP) procedures performed by a single surgeon, based on a comprehensi…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: A Study of Tadalafil in Benign Prostatic Hyperplasia [Phase 1]
This is a Phase 1 clinical trial update for tadalafil in Benign Prostatic Hyperplasia. The study has completed and results were posted in 20…
-
FDA approval · 2012-04-11FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROSCAR (finasteride) from Organon LLC. The action updates the regulatory approval for this …
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH [Phase 4]
A Phase 4 trial comparing once-daily versus twice-daily silodosin for lower urinary tract symptoms due to benign prostatic hyperplasia repor…
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) [Phase 4]
A Phase 4 clinical trial evaluating silodosin for severe benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating intraprostatic botulinum toxin A for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
Completed clinical trial evaluating whether symptom improvement predicts adherence to treatments for benign prostatic hyperplasia. The study…